Milestone Pharmaceuticals Inc Capital Reinvestment Ratio

Latest as of June 2021: 0.05x

Milestone Pharmaceuticals Inc capital reinvestment ratio. Milestone Pharmaceuticals Inc (MIST) has a Capital Reinvestment Ratio of 0.05x as of June 2021, meaning it reinvests 0% of its operating cash flow ($1.01 Million) in capital expenditures ($46.00K). Check Milestone Pharmaceuticals Inc (MIST) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.05x

Capex / Operating Cash Flow

Operating Cash Flow

$1.01 Million

USD

Capital Expenditures

$46.00K

USD

Data as of

Jun 2021

Most recent filing

Milestone Pharmaceuticals Inc Capital Reinvestment Ratio by Year (None–None)

Milestone Pharmaceuticals Inc capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see Milestone Pharmaceuticals Inc cash conversion from operations.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow